Posts tagged Antitrust Law
Open Markets Institute Statement on the FTC’s Lawsuit Reviving the Robinson-Patman Act

In response to the Federal Trade Commission initiating a lawsuit against Southern Glazer’s Wine and Spirits, LLC for engaging in unlawful price discrimination, the Open Market Institute's senior legal analyst Daniel Hanley issued a statement.

Read More
Open Markets Urges Third Circuit to Hold Merck to Account for Lying to FDA as a Means of Preserving Mumps Vaccine Monopoly

The Open Markets Institute filed an amicus brief with the U.S. Court of Appeals for the Third Circuit, urging the court to grant a rehearing In re Merck Mumps Vaccine Antitrust Litigation. A class of physicians alleged that Merck misled the Food and Drug Administration about the shelf-life of its vaccine and thereby kept out a competing vaccine.

Read More
Open Markets Submits Comments to FTC Calling for Termination of 2012 Coopharma Consent Order

Open Markets submitted a comment to the FTC calling for termination of a 2012 Coopharma consent order and urging the agency to endorse an exemption for employees, contractors and small firms that challenge concentrations of power.

Read More